Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $67367.00.
ENTERPRISE VALUE (EV)
$67367.00
Cellectar Biosciences, Inc.
Market Cap
$13.26M
Enterprise Value (EV)
$67367.00
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cellectar Biosciences, Inc. (CLRB) | $13.26M | $67367.00 |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | $5.68M |
| IN8bio, Inc. (INAB)vs › | $13.62M | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | $6.78M |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | $34.38M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | $4.44M |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | $11.18M |
| IRIDEX Corporation (IRIX)vs › | $11.94M | $11.28M |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.20M | $176.10M |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | N/A |
Market Cap
$13.26M
Total Debt
$0.00
Cash
$13.20M
Enterprise Value
$67367.00
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
